Professor Joan Guinovart, president of biochemists worldwide
For the next three years he will serve as president of the International Union of Biochemists and Molecular Biologists, an organisation that brings together biologists and biochemists from 77 countries.
During his acceptance of the presidency, Guinovart said, “it is a great honour to chair the Union” and that he will work steadfastly to strengthen the Union around the world.
As of this September and for the next three years, the director of the Institute for Research in Biomedicine (IRB Barcelona), Joan J. Guinovart, is to be at the helm of the International Union of Biochemists and Molecular Biologists (IUBMB). During the ceremony in which he accepted the presidency, which took place in the Annual Congress held in Brazil at the end of August, Prof. Guinovart declared, “it is a great honour to become president of this organisation,” and he assured those present that he would work steadfastly to increase the visibility and impact of IUBMB worldwide”. Guinovart takes over from Greg Petsko, from the Weill Cornell Medical College in the US, who has served as president for the last three years.
Guinovart, who will be the first Spanish scientist to head IUBMB, stated that his priorities include improving the teaching of biochemistry and molecular biology, encouraging the establishment of scientific societies in these disciplines in countries that do not currently have them, and promoting science among new generations. To launch these initiatives, Guinovart said with satisfaction that “IUBMB’s main strength lies in the great number of outstanding people that belong to its member organisations. The amount and quality of expertise that these people represent as a whole is immense and I count on all of them to engage in the activities of the Union”.
Set up in 1955 and registered in the Netherlands, IUBMB brings together biologists and molecular biochemists from 77 countries with the aim to promote research and education in these disciplines worldwide. Among its missions, IUBMB seeks to foster interaction between the different areas of the molecular sciences, set up networks that surpass ethnic, cultural, economic and gender barriers, create opportunities for young scientists to develop their full potential, provide counselling on science for public policy makers, promote the values and ethics of science, and assure the freedom and free movement of scientists worldwide. IUBMB has been chaired by Nobel laureates Severo Ochoa, Hugo Theorell, and Feodor Lynen, among others.
Born in Tarragona in 1947, Joan J. Guinovart holds a degree in Chemistry and a PhD in Pharmacy from the University of Barcelona (UB). He is a senior professor of Biochemistry and Molecular Biology at the UB and founding director of IRB Barcelona—a position he has held since October 2005. He is a Numerary Member of the Reial Acadèmia Nacional de Farmàcia (Institute of Spain) and of the Reial Acadèmia de Farmàcia de Catalunya, and a member of the Institut d’Estudis Catalans (IEC) and the Academia Europaea. Among other honours, he has received the "Narcís Monturiol" Medal from the Generalitat de Catalunya, the “Prat de la Riba" Award from the IEC, the Honorary Diploma from FEBS, and the Creu de Sant Jordi from the Generalitat de Catalunya.
Guinovart has served as president of the Societat Espanyola de Bioquímica i Biologia Molecular (SEBBM), and Meetings Counsellor and member of the Executive Committee of the Federation of European Biochemical Societies (FEBS), and he was also the first president of the Confederación de Sociedades Científicas de España (COSCE).
“I have channeled passion and enthusiasm into all my previous responsibilities and in all cases my input has furthered the interests of the corresponding organizations in which I was involved. I will serve IUBMB with courage and dedication, doing my utmost to strengthen and promote the Union”, said Guinovart to close his acceptace speech.
Dr. Guinovart’s research interests focus on glycogen metabolism, specifically in relation to diabetes and neurodegenerative diseases such as Lafora disease.
Related content
News
On Monday 22 October, the Dolors Aleu Hall registered a full house, with more than 170 people gathering to celebrate the long and successful career of Joan J. Guinovart. Authorities, current and former members of the Board of Trustees, scientific collaborators, family members, representatives from philanthropic institutions, members of IRB Barcelona, and former students accompanied the founder and former director of the institute during 13 years on this special occasion. Indeed, due to interest in the event, it was retransmitted by video streaming in an annex hall.
The newspaper “El Periódico” has published an article about the campaign to host the new headquarters of the London-based European Medicines Agency (EMA) after Brexit.
The article echoes the opinion of several leading figures, including IRB Barcelona director Joan J. Guinovart. "The presence of the EMA would turn Barcelona into a tremendous great focus on well-being and wealth for the whole of Europe," he stresses.
Science Magazine publishes a report on the official launch of European Molecular Biology Laboratory's (EMBL) sixth site, in Barcelona. The new branch, housed at the Barcelona Biomedical Research Park (PRBB), will focus on tissue biology and disease modelling.
The agreement between the EMBL and the Spanish government strengthens Barcelona's profile as one of southern Europe's premier science hubs, stresses Joan Guinovart, director of the Institute for Research in Biomedicine, in Science Magazine. “Barcelona is already one of the hottest spots in biomedicine in Europe," he adds.
